• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Wednesday, March 29, 2023
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Latte lovers rejoice! Study reveals drinking coffee could lower the risk of Alzheimer’s disease

Bioengineer by Bioengineer
November 23, 2021
in Biology
Reading Time: 4 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Good news for those of us who can’t face the day without their morning flat white: a long-term study has revealed drinking higher amounts of coffee may make you less likely to develop Alzheimer’s disease. 

Dr Samantha Gardener.

Credit: Edith Cowan University.

Good news for those of us who can’t face the day without their morning flat white: a long-term study has revealed drinking higher amounts of coffee may make you less likely to develop Alzheimer’s disease. 

As part of the Australian Imaging, Biomarkers and Lifestyle Study of ageing, researchers from Edith Cowan University (ECU) investigated whether coffee intake affected the rate of cognitive decline of more than 200 Australians over a decade.  

Lead investigator Dr Samantha Gardener said results showed an association between coffee and several important markers related to Alzheimer’s disease. 

“We found participants with no memory impairments and with higher coffee consumption at the start of the study had lower risk of transitioning to mild cognitive impairment – which often precedes Alzheimer’s disease – or developing Alzheimer’s disease over the course of the study,” she said. 

Drinking more coffee gave positive results in relation to certain domains of cognitive function, specifically executive function which includes planning, self-control, and attention. 

Higher coffee intake also seemed to be linked to slowing the accumulation of the amyloid protein in the brain, a key factor in the development of Alzheimer’s disease.  

Dr Gardener said although further research was needed, the study was encouraging as it indicated drinking coffee could be an easy way to help delay the onset of Alzheimer’s disease. 

“It’s a simple thing that people can change,” she said. 

“It could be particularly useful for people who are at risk of cognitive decline but haven’t developed any symptoms.

“We might be able to develop some clear guidelines people can follow in middle age and hopefully it could then have a lasting effect.” 

Make it a double 

If you only allow yourself one cup of coffee a day, the study indicates you might be better off treating yourself to an extra cup, although a maximum number of cups per day that provided a beneficial effect was not able to be established from the current study.  

“If the average cup of coffee made at home is 240g, increasing to two cups a day could potentially lower cognitive decline by eight per cent after 18 months,” Dr Gardener said.  

“It could also see a five per cent decrease in amyloid accumulation in the brain over the same time period.”  

In Alzheimer’s disease, the amyloid clumps together forming plaques which are toxic to the brain. 

The study was unable to differentiate between caffeinated and de-caffeinated coffee, nor the benefits or consequences of how it was prepared (brewing method, the presence of milk and/or sugar etc). 

Dr Gardener said the relationship between coffee and brain function was worth pursuing. 

“We need to evaluate whether coffee intake could one day be recommended as a lifestyle factor aimed at delaying the onset of Alzheimer’s disease,” she said. 

More than just caffeine 

Researchers are yet to determine precisely which constituents of coffee are behind its seemingly positive effects on brain health. 

Though caffeine has been linked to the results, preliminary research shows it may not be the sole contributor to potentially delaying Alzheimer’s disease. 

“Crude caffeine” is the by-product of de-caffeinating coffee and has been shown to be as effective in partially preventing memory impairment in mice, while other coffee components such as cafestol, kahweol and Eicosanoyl-5-hydroxytryptamide have also been seen to affect cognitive impairment in animals in various studies. 

‘Higher Coffee Consumption Is Associated With Slower Cognitive Decline and Less Cerebral Aβ-Amyloid Accumulation Over 126 Months: Data From the Australian Imaging, Biomarkers, and Lifestyle Study’ was published in Frontiers of Ageing Neuroscience.  

 

– ends – 

Media contact: Sam Jeremic, 08 6304 2367 or 0407 601 993, [email protected] 

Sign up to get the latest research news and media releases delivered to your inbox. 



Journal

Frontiers in Aging Neuroscience

DOI

10.3389/fnagi.2021.744872

Method of Research

Survey

Subject of Research

People

Article Title

Higher Coffee Consumption Is Associated With Slower Cognitive Decline and Less Cerebral Aβ-Amyloid Accumulation Over 126 Months: Data From the Australian Imaging, Biomarkers, and Lifestyle Study

Article Publication Date

19-Nov-2021

COI Statement

VV has served as a consultant for IXICO. CM is an advisor to Prana Biotechnology Ltd., and a consultant to Eli Lilly. PM is a full-time employee of Cogstate Ltd. CR has served on scientific advisory boards for Bayer Pharma, Elan Corporation, GE Healthcare, and AstraZeneca, has received speaker honoraria from Bayer Pharma and GE Healthcare, and has received research support from Bayer Pharma, GE Healthcare, Piramal Lifesciences and Avid Radiopharmaceuticals. RM is founder of, and owns stock in, Alzhyme, and is a co-founder of the KaRa Institute of Neurological Diseases.

The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Share12Tweet8Share2ShareShareShare2

Related Posts

Unique trackway on Permian Karoo shoreline provides evidence of temnospondyl locomotory behaviour

Ancient giant amphibians swam like crocodiles 250 million years ago

March 29, 2023
https://www.cnio.es/noticias/investigadores-del-cnio-ayudan-a-entender-como-funciona-la-proteina-que-hace-lazos-de-adn-en-el-genoma-humano/

CNIO researchers help to understand the functioning of the protein that makes DNA loops in the human genome

March 29, 2023

WVU researcher prototypes new equipment to improve head and neck cancer treatment

March 29, 2023

Scientists discover hidden crab diversity among coral reefs

March 29, 2023

POPULAR NEWS

  • ChatPandaGPT

    Insilico Medicine brings AI-powered “ChatPandaGPT” to its target discovery platform

    67 shares
    Share 27 Tweet 17
  • Northern and southern resident orcas hunt differently, which may help explain the decline of southern orcas

    44 shares
    Share 18 Tweet 11
  • Skipping breakfast may compromise the immune system

    43 shares
    Share 17 Tweet 11
  • Insular dwarfs and giants more likely to go extinct

    35 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Senescence and extracellular vesicles: novel partners in vascular amyloidosis

Groundbreaking lymphoma tumor model paves way for new therapies

Mimicking biological enzymes may be key to hydrogen fuel production

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 48 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In